1Y Annualised Return
▲34.74%
3Y Annualised Return
▲40.25%
5Y Annualised Return
▲33.29%
Over the past
Open
431.50
Prev. Close
431.50
Total Traded Value
10.72 L
Market Cap (in crs)
685.75
Face Value
10
Turnover (in lacs)
10.72
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
61.23 Cr | 56.17 Cr | 47.47 Cr | 33.45 Cr | 44.82 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
209.48 Cr | 158.85 Cr | 142.52 Cr | 117.14 Cr | 71.19 Cr | 57.45 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
10.22 Cr | 5.61 Cr | 8.61 Cr | 0.11 Cr | 3.68 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
24.56 Cr | 13.58 Cr | 8.28 Cr | 6.21 Cr | 3.77 Cr | 0.84 Cr |
Kilitch Drugs (India) Ltd reported a 21.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 2.6%.
Its expenses for the quarter were down by 19.4% QoQ and 3.4% YoY.
The net profit decreased 34.4% QoQ and increased 26.9% YoY.
The earnings per share (EPS) of Kilitch Drugs (India) Ltd stood at 2.2 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 3931 Rs | 3931 Rs |
Week Rs | 9541 Rs | 9541 Rs |
Month Rs | 24535 Rs | 44077 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105.80 | 637.29 | 68.72 | 186 | 106.50 | -0.16% | 45.61% | -2.93% | -9.75% | 79.25% | 0.00% | 7.09 | 41.51 | 0.62 | |
614.91 | 957 | 2777.95 | 1,000.00 | -4.23% | -20.98% | -49.76% | -57.86% | 0.00% | 0.00% | 34.08 | 41.51 | 2.21 | ||
511.70 | 615.70 | 250 | 515 | 426.45 | 7.83% | 28.02% | 28.31% | 59.53% | 643.75% | 0.00% | 0.00 | 41.51 | 24.51 | |
601.30 | 773.99 | 600 | 950.05 | 605.45 | -1.84% | -2.10% | -11.36% | -28.02% | 158.19% | 0.00% | 33.52 | 41.51 | 5.33 | |
771.42 | 802 | 1870 | 1,128.05 | -6.20% | -3.67% | -31.74% | -19.36% | 247.45% | 0.09% | 29.16 | 41.51 | 1.99 | ||
358.50 | 788.99 | 210.1 | 380.8 | 349.25 | 12.73% | 14.51% | 18.89% | 14.73% | 129.53% | 0.00% | 44.99 | 41.51 | 2.76 |
As of 23 Jun, 2025, Kilitch Drugs (India) share price is ₹426.4. The stock opened at ₹431.5 and had closed at ₹431.5 the previous day. During today’s trading session, Kilitch Drugs (India) share price moved between ₹426.00 and ₹436.65, with an average price for the day of ₹431.32. Over the last 52 weeks, the stock has recorded a low of ₹299.95 and a high of ₹499.00. In terms of performance, Kilitch Drugs (India) share price has increased by 31.7% over the past six months and has increased by 34.74% over the last year.
Kilitch Drugs (India) share price is ₹426.4 in NSE and ₹432.8 in BSE as on 23/6/2025.
Kilitch Drugs (India) share price in the past 1-year return was 31.22. The Kilitch Drugs (India) share hit a 1-year low of Rs. 299.95 and a 1-year high of Rs. 499.
The market cap of Kilitch Drugs (India) is Rs. 685.75 Cr. as of 23/6/2025.
The PE ratios of Kilitch Drugs (India) is 21.93 as of 23/6/2025.
The PB ratios of Kilitch Drugs (India) is 2.7 as of 23/6/2025
You can easily buy Kilitch Drugs (India) shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Kilitch Drugs (India) stock prices are subject to continuous fluctuations due to various factors.